Morning Overview on MSN
One-shot vaccine injected into tumors shows promise for boosting survival
A single injection of a redesigned immune-stimulating antibody directly into a tumor was linked to shrinkage not only at the ...
EVEREST-2: A seamless phase 1/2 study of A2B694, a logic-gated Tmod chimeric antigen receptor T-cell (CAR T) therapy, in patients with pancreatic cancer (PANC) or other mesothelin (MSLN)-expressing ...
BOSTON--(BUSINESS WIRE)--Boston Immune Technologies and Therapeutics, Inc. (BITT), a clinical-stage biotechnology company developing novel tumor necrosis factor superfamily receptor (TNFSR) antagonist ...
Genomic landscape of acquired resistance to targeted therapies in metastatic colorectal cancer (mCRC). This is an ASCO Meeting Abstract from the 2023 ASCO Gastrointestinal Cancers Symposium. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results